Skip to main content

Advancing acute respiratory failure management through artificial intelligence: a call for thematic collection contributions

In recent years, artificial intelligence (AI) has permeated virtually every facet of modern life, revolutionizing industries from finance to transportation, and now, healthcare [1]. The COVID-19 pandemic has starkly illuminated the vulnerability of our healthcare systems when faced with sudden surges in critically ill patients, particularly those with respiratory complications. The need for rapid, accurate diagnosis and personalized treatment plans has never been more pressing [2, 3]. AI offers a unique opportunity to analyze vast amounts of data with unprecedented speed and accuracy, which can lead to breakthroughs in early detection, prevention, and treatment strategies for ARF [4]. ARF patients are usually treated with mechanical ventilation in the intensive care unit and parameters of mechanical ventilation are continuous (validated every minute) and hence the dynamics of MV provide a large amount of data which are difficult to analyze without AI.

The motivation to launch this thematic collection is rooted in the recognition of the potential power of AI, which, when integrated with clinical expertise, can significantly enhance patient care. By leveraging AI's predictive analytics, we can improve clinical decision-making, optimize resource allocation, and develop more targeted interventions. Moreover, AI's ability to process complex imaging and physiological data can facilitate a deeper understanding of the pathophysiological mechanisms underlying acute respiratory failure, paving the way for novel therapeutic approaches [5, 6].

In this context, the collection aims to bring together the latest research and insights at the intersection of AI and ARF management. We seek to highlight the innovative applications of AI that can transform the way we approach this critical condition, from the initial triage to the long-term management of complications. By showcasing the potential of AI to revolutionize the management of ARF, such as risk stratification, subphenotype identification and individualized treatment, we hope to galvanize the healthcare providers in critical care setting to adopt these cutting-edge technologies, ultimately leading to improved ARF outcomes and a more resilient healthcare system in the face of future challenges.

The scope of this thematic collection is broad and ambitious. We welcome (1) original researches that delves into the development and validation of AI algorithms for early prediction, diagnosis, risk stratification, prognosis assessment, and treatment of ARF; (2) studies that demonstrate the integration of AI-driven decision support systems into clinical practice, optimizing mechanical ventilation strategies and patient monitoring; (3) submissions that explore novel data sources such as imaging and multi-omics data and AI-driven analytics for continuous monitoring, prediction, and management of acute respiratory failure exacerbations; (4) researches addressing ethical considerations, challenges, and opportunities associated with the adoption of AI technologies in acute respiratory failure management.

The research published in this collection will have a profound impact on patient outcomes, enabling earlier detection, more accurate diagnosis, and optimized treatment strategies. We are committed to fostering a dialogue that bridges the gap between AI research and clinical application, ensuring that the latest advancements benefit those who need it most. We invite researchers, clinicians, and industry professionals to join us in shaping the future of acute respiratory failure management.

Availability of data and materials

Not applicable.

References

  1. Messeri L, Crockett MJ (2024) Artificial intelligence and illusions of understanding in scientific research. Nature 627:49–58. https://doi.org/10.1038/s41586-024-07146-0

    Article  CAS  PubMed  Google Scholar 

  2. Bouchareb Y, Moradi Khaniabadi P, Al Kindi F et al (2021) Artificial intelligence-driven assessment of radiological images for COVID-19. Comput Biol Med 136:104665. https://doi.org/10.1016/j.compbiomed.2021.104665

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Suri JS, Agarwal S, Gupta SK et al (2021) A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence. Comput Biol Med 130:104210. https://doi.org/10.1016/j.compbiomed.2021.104210

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hong Y, Chen L, Pan Q et al (2021) Individualized Mechanical power-based ventilation strategy for acute respiratory failure formalized by finite mixture modeling and dynamic treatment regimen. EClinicalMedicine 36:100898. https://doi.org/10.1016/j.eclinm.2021.100898

    Article  PubMed  PubMed Central  Google Scholar 

  5. Vliegenthart R, Fouras A, Jacobs C, Papanikolaou N (2022) Innovations in thoracic imaging: CT, radiomics, AI and x-ray velocimetry. Respirology 27:818–833. https://doi.org/10.1111/resp.14344

    Article  PubMed  PubMed Central  Google Scholar 

  6. Röhrich S, Hofmanninger J, Prayer F et al (2020) Prospects and challenges of radiomics by using nononcologic routine chest CT. Radiol Cardiothoracic Imaging 2:e190190. https://doi.org/10.1148/ryct.2020190190

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

Z.Z received funding from the China National Key Research and Development Program [2022YFC2504503, 2023YFC3603104], a collaborative scientific project co-established by the Science and Technology Department of the National Administration of Traditional Chinese Medicine and the Zhejiang Provincial Administration of Traditional Chinese Medicine [GZY-ZJ-KJ-24082], General Health Science and Technology Program of Zhejiang Province [2024KY1099], the Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China [LHDMD24H150001], National Natural Science Foundation of China [82272180], and the Project of Drug Clinical Evaluate Research of Chinese Pharmaceutical Association [CPA-Z06-ZC-2021-004].

Author information

Authors and Affiliations

Authors

Contributions

Z.Z. dafted the manuscript and JW provided critical review.

Corresponding author

Correspondence to Zhongheng Zhang.

Ethics declarations

Ethics approval and consent to participate

Not applicabale.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Z., Wittenstein, J. Advancing acute respiratory failure management through artificial intelligence: a call for thematic collection contributions. ICMx 12, 45 (2024). https://doi.org/10.1186/s40635-024-00629-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40635-024-00629-4